Search Results

Displaying Results 401-425 of 1130 "'WU'"

Feb 06, 2026, 00:10 ET 雲頂新耀宣佈中國國家藥品監督管理局批准維適平®用於治療中重度潰瘍性結腸炎的新藥上市許可申請

療不需要複雜的滴定方案。在ELEVATE UC 52和ELEVATE UC 12中,分別有近三分之二的患者既往從未接受過生物制劑或JAK抑制劑治療。參考文獻:[1] K. Wu, et al. Lancet Gastroenterol Hepatol. 2025 Sep 30:S2468-1253(25)00198-0.[2] Shao B, et al. Front Public Health. 2022 Oct 25;10:1032679.   

More news about: 雲頂新耀


Feb 05, 2026, 11:00 ET DeltaTrak Expands Inbound Compliance Options for Fresh Suppliers with New FlashLink NOW Real-Time Loggers

shipment."Retailer inbound programs are becoming more data-driven and less forgiving when it comes to temperature and arrival time compliance," said Fred Wu, CEO of DeltaTrak. "DeltaTrak enables suppliers to move from retrospective reporting to real-time insight, helping them respond faster and reduce risk.

More news about: DeltaTrak


Feb 05, 2026, 09:35 ET $207B Market Shift: The Race for Fast Track Approval in Oncology

critical hires: John McAdory as Executive Vice President of Strategy and Operations, who ran late-stage clinical trials at CG Oncology, and Yujun Wu as Vice President, Head of Biostatistics, who led statistics at Morphic Therapeutic through its sale to Eli Lilly. Kelly and Chief Business

More news about: USA News Group


Feb 04, 2026, 10:01 ET Cuidados com a pele pós-férias: como adaptar a rotina de skincare após dias de sol intenso

2. Belmontesi 2018 Skinbooster-JDD-01.182. Streker M, Reuther T, Krueger N, et al. Drugs Dermatol. 2013 Jan;12(9):990-9943. Wu Y, et al. J Cosmet Dermatol. 2020 Jul;19(7):1627-1635. 4. Belmontesi M, et al. J Drugs Dermatol. 2018 Jan 1 ;17(1):83-88.5. Dierickx

More news about: Galderma


Feb 02, 2026, 04:31 ET Wu Zuyu de Hithium invitado a reunirse con el primer ministro del Reino Unido

discursos, respectivamente. Más de 110 representantes de empresas e instituciones de China y el Reino Unido participaron en la reunión, incluyendo a Wu Zuyu, de Hithium, quien fue invitado. El primer ministro Starmer declaró

More news about: HiTHIUM


Feb 01, 2026, 17:53 ET Wu Zuyu von Hithium zu einem Treffen mit dem britischen Premierminister eingeladen

jeweils Reden. Mehr als 110 Vertreter von Unternehmen und Institutionen aus China und dem Vereinigten Königreich nahmen an dem Treffen teil, darunter auch Wu Zuyu von Hithium, der zu dem Treffen eingeladen war. Premierminister Starmer

More news about: HiTHIUM


Feb 01, 2026, 17:46 ET Wu Zuyu de Hithium invité à rencontrer le premier ministre britannique

prononcé des discours respectifs. Plus de 110 représentants d'entreprises et d'institutions de Chine et du Royaume-Uni ont participé à la réunion, y compris Wu Zuyu de Hithium, qui avait été invité à y assister. Le Premier ministre Starmer

More news about: HiTHIUM


Feb 01, 2026, 13:49 ET Wu Zuyu of Hithium Invited to Meet with UK Prime Minister

speeches respectively. More than 110 representatives of enterprises and institutions from both China and the UK participated in the meeting, including Wu Zuyu from Hithium, who was invited to attend. Prime Minister Starmer stated

More news about: HiTHIUM


Jan 30, 2026, 16:10 ET Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

time to time, whether as a result of new information, future developments or otherwise.Contacts:For Investors:Vivian Wu[email protected] Davis, Ph.D.LifeSci Advisors, LLC

More news about: Nektar Therapeutics


Jan 30, 2026, 14:16 ET Comienza la cuenta atrás para la Gala del Festival de Primavera de 2026 ¡Nos vemos en Yiwu!

En el evento flash mob, los invitados Yu Shanshan y Wu Dailin transmitieron la alegría del Festival de Primavera a través de sus canciones, energizando repetidamente a la multitud. Ambos invitados expresaron

More news about: Yiwu Media Convergence Center


Jan 30, 2026, 13:40 ET Galderma promove treinamentos e reforça compromisso com a educação continuada em estética injetável durante o CIOSP

2018 Jan 1;17(1):83-88. 15. Kerscher M et al. Presented at IMCAS World Congress Paris, France. January 26-29, 2017 16. Wu Y et al. J Cosmet Dermatol. 2020 Jul;19(7):1627-1635. 17. Philipp-Dormston WG, et al. Dermatol Surg. 2018 Jun;44(6):826-832 18.

More news about: Galderma


Jan 30, 2026, 10:36 ET $170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium

President of Strategy and Operations, and Yujun Wu as Vice President, Head of Biostatistics. McAdory comes from CG Oncology, where he ran late-stage clinical trials for oncolytic virus therapies (cancer-fighting viruses, similar to pelareorep). Wu joins from Morphic Therapeutic, where he

More news about: Equity Insider


Jan 30, 2026, 10:19 ET $668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors

President of Strategy and Operations, and Yujun Wu as Vice President, Head of Biostatistics. McAdory comes from CG Oncology, where he ran late-stage clinical trials for oncolytic virus therapies (cancer-fighting viruses, similar to pelareorep). Wu joins from Morphic Therapeutic, where he

More news about: USA News Group


Jan 29, 2026, 10:00 ET Women's Health, Sports & Performance Institute Launches as First-of-Its-Kind Organization for Female Athletes

advancements for women. "Over the last five years, Dr. Ackerman has led the Wu Tsai Human Performance Alliance's research on female athletes, an area chronically understudied and underfunded," said Wu Tsai. "Through both the Alliance and WHSP, I'm thrilled to continue supporting this

More news about: WHSP


Jan 29, 2026, 09:30 ET ANNOUNCING GONG CHA 2.0: A NEW ERA OF INNOVATION, EFFICIENCY AND GROWTH

heritage."Super Wu: Automated Beverage IntelligenceAt the heart of Gong cha 2.0 is the Super Wu system, a beverage automation platform that brings real-time intelligence and speed to drink prep. Named after Gong cha founder, Wu Zhenhua, Super Wu automates the repetitive steps

More news about: Gong cha


Jan 28, 2026, 20:00 ET Nona Biosciences Co-founds Innovative Alliance for Translational Medicine in Immunological Diseases, Advancing a New IIT-Driven Ecosystem

Dr. Di Hong, CEO of Nona Biosciences, represented the industry and engaged in in-depth discussions with distinguished experts including Prof. Yuzhang Wu, Academician of the Chinese Academy of Engineering, Prof. Zhanguo Li, and leaders from multiple medical institutions, focusing on accelerating breakthroughs

More news about: Nona Biosciences


Jan 28, 2026, 09:15 ET Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment

recently announced the appointments of John McAdory as Executive Vice President of Strategy and Operations and Yujun Wu as Vice President, Head of Biostatistics, bringing deep expertise in late-stage oncology trial execution and regulatory strategy. McAdory joins from

More news about: USA News Group


Jan 28, 2026, 08:00 ET Cognizant and Cognition Partner to Scale Autonomous Software Engineering and Deliver Business Value Across Enterprise Operations

meaningful scale."We are excited to partner with Cognizant to bring autonomous software engineering into real enterprise environments," said Scott Wu, Founder and CEO of Cognition. "Cognizant's depth in engineering, delivery, and transformation makes them a strong partner for scaling agentic and autonomous

More news about: Cognizant Technology Solutions


Jan 28, 2026, 03:30 ET Youdao to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 11

89980E-mail: [email protected] Piacente Financial CommunicationsHelen WuTel: +86-10-6508-0677E-mail: [email protected] In

More news about: Youdao, Inc.


Jan 27, 2026, 10:50 ET Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks

recently announced the appointments of John McAdory as Executive Vice President of Strategy and Operations and Yujun Wu as Vice President, Head of Biostatistics, bringing deep expertise in late-stage oncology trial execution and regulatory strategy. McAdory joins from

More news about: Equity Insider


Jan 26, 2026, 08:34 ET SourcingAI Bridges Global Sourcing Gap with Multilingual Launch, Redefining How Buyers Find Chinese Suppliers

agent built by Made-in-China.com. Its mission is to make global sourcing simpler and more reliable for buyers worldwide.Contact:Yichun Wu[email protected]

More news about: SourcingAI


Jan 26, 2026, 08:30 ET Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key Capital

broader healthcare sector."This partnership represents an extension of our global vision rather than a mere geographic expansion," said Mrs. Haimei Wu, Chairwoman of Baird Medical. "By positioning the Free Trade Port as a critical pivot point connecting supply chain resilience with medical innovation,

More news about: BDMD


Jan 25, 2026, 19:10 ET Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes

provides us with another chance to highlight ASC30's potential best-in-class profile as a once-daily oral treatment option for patients," said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis, "We look forward to sharing topline data from the Phase II study in diabetes participants in the third

More news about: Ascletis Pharma Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.